TrialPain medicine (Malden, Mass.)2020

Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back Pain.

Jack E Henningfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.